Skip to content

Clinical trials

Non-alcoholic Fatty Liver Disease trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Country / region: United States Clear all

545 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20022
20034
20044
200512
200610
200710
200817
200910
20109
20116
201211
201318
201420
201532
201627
201726
201836
201962
202039
202157
202238
202337
202429
202516
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed345
Terminated71
Recruiting51
Active, not recruiting32
Unknown status20
Withdrawn15
Not yet recruiting4
Enrolling by invitation4
Suspended3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)20
Gilead Sciences16
Massachusetts General Hospital15
University of California, San Diego13
Columbia University11
Pfizer11
GlaxoSmithKline10
Yale University9
Bristol-Myers Squibb8
Corcept Therapeutics8

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease545
Fatty Liver115
Obesity80
Liver Diseases52
Fibrosis49
Liver Cirrhosis43
Diabetes Mellitus, Type 240
Insulin Resistance36
Diabetes Mellitus27
Metabolic Syndrome18

Trials

Showing 1 to 25 of 545. Each trial links to its page on Pharma Observatory.

445 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.